Patient-Reported Outcomes and Experiences Assessment in Women with Breast Cancer

Autor: Anabela Coelho, Candan Kendir, Eliana Barrenho, Niek Klazinga, Cláudia Paiva, Joaquim Abreu de Sousa, Salomé Gonçalves-Monteiro, Patrícia Redondo, Ana Bastos, Armanda Nogueira, Fábio Botelho Guedes, Andreia Silva Costa, Tânia Gaspar

Publikováno v: International journal of environmental research and public health, 20(4):2931. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Environmental Research and Public Health
Volume 20
Issue 4
Pages: 2931

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
In 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855be81c9af149ce255c8e199461a962
http://www.scopus.com/inward/record.url?scp=85148964545&partnerID=8YFLogxK

The impact of the priority review voucher on research and development for tropical diseases

Autor: Celine Aerts, Eliana Barrenho, Marisa Miraldo, Elisa Sicuri

Background In 2007, the priority review voucher (PRV) was implemented in the US to incentivize research and development (R&D) for tropical diseases. The PRV is issued by the US FDA and grants a quicker review to manufacturers upon successful developm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1effc378341e90cd6ac49da4f42bd89
http://hdl.handle.net/10044/1/97923

Inequities in cancer drug development in terms of unmet medical need

Autor: Eliana Barrenho, Réka Halmai, Marisa Miraldo, Iván Tzintzun, Setti Raïs Ali, Léa Toulemon, Jean-Claude K. Dupont, Lise Rochaix

Publikováno v: Social sciencemedicine (1982). 302

This study measures inequality and inequity in the distribution of clinical trials on cancer drug development between 1996 and 2016, comparing the number of clinical trials with cancer need, proxied by prevalence, incidence, or survival rates for bot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c68df2a90dbfcd1ef1ef2eb036756dbc
https://pubmed.ncbi.nlm.nih.gov/35489114

Vertical and horizontal equity of funding for malaria control: a global multisource funding analysis for 2006–2010

Autor: Mujaheed Shaikh, Eliana Barrenho, Marisa Miraldo, Rifat Atun

Publikováno v: BMJ Global Health

Background International and domestic funding for malaria is critically important to achieve the Sustainable Development Goals. Its equitable distribution is key in ensuring that the available, scarce, resources are deployed efficiently for improved

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7b0bd674df2a35a3fa86e2c517f2904
https://research.wu.ac.at/de/publications/49d8db56-7958-42d8-8711-cf73d160831b

Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries

Autor: Eliana Barrenho, Marisa Miraldo, Peter C. Smith

Publikováno v: Health economics. 28(1)

Although it is commonly argued that there is a mismatch between drug innovation and disease burden, there is little evidence on the magnitude and direction of such disparities. In this paper, we measure inequality in innovation, by comparing research

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcac6afc072cdf2c913bf47fdf10b4e9
https://pubmed.ncbi.nlm.nih.gov/30417950